In Silico Clinical Trials

27 Sep 2016
10:30-12:30
Plenary Room

In Silico Clinical Trials

Previous SessionBack to Program Next Session

chair person: Marco Viceconti

 

time speaker title
10:30-11:00
(invited)
Liesbet Geris An in silico clinical trial for the evaluation of growth factor treatment of congenital pseudarthrosis of the tibia in children with Neurofibromatosis type I
11:00-11:30
(invited)
Luca Emili InSilicoClinicalTrial.com platform helps the scientific community define Good Simulation Practice
11:30-11:50 Jan Osman Impact of Patient-Specific LVOT Inflow on Aortic Valve and Ascending Aorta Hemodynamics
11:50-12:10 David Nolan A Mechanobiological Framework for the Prediction of In-Stent Restenosis; Insights into the role of load induced damage in restenotic growth
12:10-12:30 Georgios Stamatakos In Silico Oncology: Evaluating the Predictability of Acute Lymphoblastic Leukemia Patients’ Response to Treatment Utilizing a Multiscale Oncosimulator Model in Conjunction with Machine Learning Methods